MELE, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 76
NA - Nord America 75
AS - Asia 40
Totale 191
Nazione #
US - Stati Uniti d'America 74
IT - Italia 53
CN - Cina 21
SG - Singapore 16
FI - Finlandia 6
DE - Germania 5
AT - Austria 3
GB - Regno Unito 3
CZ - Repubblica Ceca 2
FR - Francia 2
IN - India 2
ES - Italia 1
IE - Irlanda 1
KR - Corea 1
PA - Panama 1
Totale 191
Città #
Florence 38
Boardman 27
Singapore 14
Ashburn 8
Shanghai 8
Helsinki 5
Sesto Fiorentino 5
Los Angeles 4
Noto 4
Washington 4
Bari 3
Vienna 3
Enfield 2
Munich 2
New York 2
Raipur 2
Chicago 1
Cirò Marina 1
Dublin 1
Guangzhou 1
Jinhua 1
Lappeenranta 1
Madrid 1
Seoul 1
Tiantai Chengguanzhen 1
Wuhan 1
Zhengzhou 1
Totale 142
Nome #
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 37
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients 37
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 31
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 28
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 23
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience 18
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials 18
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials 7
Totale 199
Categoria #
all - tutte 1.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.828


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202311 0 0 0 0 0 0 7 0 0 0 4 0
2023/2024122 2 2 22 20 8 15 8 1 1 2 5 36
2024/202566 2 18 5 10 16 15 0 0 0 0 0 0
Totale 199